New Yorkers who suffer from endometriosis may be interested in learning about an assessment conducted by researchers at Yale School of Medicine. This disease, which impacts as much as 10 percent of American women who are old enough to bear children, can cause worsening pelvic pain and debilitating menstrual cramps. Globally, endometriosis may be the cause of symptoms like infertility and pelvic pain in up to 50 percent of sufferers.
According to news reports, the findings discussed at the May 2017 World Congress on Endometriosis put forth the idea that tracking certain biomarkers could help doctors diagnose and treat endometriosis earlier. Since misdiagnosis is a huge problem that affects almost two-thirds of women with endometriosis, researchers believe that the study could be a critical turning point in managing the disease.
On average, women in America must wait for several years before they receive the correct diagnosis of endometriosis. Around 46 percent of sufferers who receive the right diagnosis have to go through five doctors in the process. With the U.S. costs of endometriosis treatment, diagnosis and other expenses reaching around $69 billion in 2009, biomarkers that permit faster disease identification might change the lives of millions of women.
Women who suffer from conditions like endometriosis may find that their doctors’ failure to properly diagnose them results in serious ramifications. In addition to the reduced quality of life that they experience while they deal with severe pain and other symptoms, they might end up paying more for treatment that should have started when their diseases were less advanced. Diagnostic medical errors can also result in them receiving treatment for the wrong conditions. Lawyers might be able to help them pursue settlements to offset such costs.
